{
    "_id": {
        "$oid": "684bfcbfdbaab2cbd3ea8b61"
    },
    "publishedDate": {
        "$date": "2025-05-14T06:07:09.560Z"
    },
    "title": "Acumen Pharmaceuticals Inc (ABOS) Q1 2025 Earnings Call Highlights: Strategic Advancements Amid ...",
    "url": "https://www.gurufocus.com/news/2860982/acumen-pharmaceuticals-inc-abos-q1-2025-earnings-call-highlights-strategic-advancements-amid-financial-challenges",
    "description": "\nCash and Marketable Securities: $197.9 million as of March 31, 2025.R&D Expenses: $25.3 million in Q1 2025.G&A Expenses: $5.1 million in Q1 2025.Loss from Oper",
    "source": "gurufocus.com",
    "tickers": [
        "ABOS",
        "NE-WS"
    ]
}